Table 1.

The change trends of levels of miR-93, miR-373, and miR-17−5p and the level of TBP-2 protein in lung cancer tissues compared to normal noncancerous tissues (36 samples).

Patient#	TBP-2 prot (can vs. nor)	miR-93 (can vs. nor)	miR-373 (can vs. nor)	miR-17-5p (can vs. nor)
1	Lower	Higher	Higher	Higher
2	Lower	Lower	Lower	Higher
3	Lower	Higher	Lower	Higher
4	Lower	Lower	Higher	Higher
5	Lower	Higher	Higher	Lower
6	Lower	Higher	Higher	Higher
7	Lower	Higher	Higher	Higher
8	Lower	Higher	Higher	Higher
9	Lower	Higher	Higher	Higher
10	Higher	Higher	Lower	Lower
11	Lower	Higher	Higher	Higher
12	Lower	Lower	Higher	Lower
13	Lower	Higher	Higher	Higher
14	Higher	Higher	Higher	Higher
15	Lower	Higher	Higher	Higher
16	Lower	Lower	Higher	Higher
17	Lower	Lower	Higher	Higher
18	Lower	Higher	Higher	Lower
19	Lower	Higher	Higher	Lower
20	Higher	Higher	Lower	Lower
21	Lower	Higher	Lower	Higher
22	Lower	Higher	Higher	Lower
23	Lower	Higher	Higher	Higher
24	Lower	Lower	Higher	Higher
25	Higher	Lower	Higher	Higher
26	Lower	Lower	Higher	Higher
27	Lower	Lower	Lower	Higher
28	Lower	Higher	Higher	Higher
29	Lower	Higher	Higher	Higher
30	Lower	Higher	Lower	Lower
31	Lower	Higher	Higher	Higher
32	Lower	Higher	Higher	Higher
33	Higher	Higher	Lower	Higher
34	Higher	Higher	Higher	Lower
35	Lower	Lower	Higher	Higher
36	Lower	Higher	Higher	Higher

Text in red shows that the correlation between TBP2 and miRs is not always direct.